TMT January Issue LIVE!!

Published: Tue, 02/02/21

New Covid 19 and Specialty Telehealth Market & Research Published

Telehealth research, innovation and service solutions continue to present as the pandemic rages. Clinicians and subject matter experts treating patients in the telehealth sector continue to strive to find optimal care solutions with fallout igniting a new business sector within healthcare.

The January 2021 issue of the gold open access journal Telehealth and Medicine Today (TMT) presents some of the newest and vetted pilots and market research from the last few months. In addition, the coveted annual “2021 Telehealth Predictions” presents a market prognosis from 17 multidisciplinary global experts.

The read the newest original research, click the link below:

Stay tuned - the upcoming issue of TMT will feature Proceedings of 16th International Conference of the Telemedicine Society of India, Dec 2020.

To submit an original manuscript for the July 2021 TMT issue visit:
https://telehealthandmedicinetoday.com/index.php/journal/about/submissions

DEADLINE: June 1, 2021

Subscribe Here

About | Telehealth and Medicine Today (TMT) is a leading international peer review journal where multidisciplinary stakeholders converge to address strategic, medical, technical, economic, legal, regulatory and societal aspects of this growing health technology and service sector. The journal assists building knowledge and consensus to deploy and scale delivery services to achieve sustainable outcomes for affordable, accessible, and quality care for health consumers around the globe in a value based system. A world-class review board endeavors to offer rapid peer-review and includes constructive commentary to strengthen work. Published quarterly, the journal registers original research article provenance on the blockchain for the scientific research community.

For journal Archives go to https://telehealthandmedicinetoday.com/index.php/journal

Technology & Data Harmonization to Enable Decentralized Clinical Trials
“There continue to be concerns over patient privacy and verification, data validation and security, and uncertainties with regulatory compliance,” Maria Palombini, Director of Emerging Communities, IEEE SA. “There are many unanswered questions, so there’s quite a bit of hesitancy in transitioning to this approach to conducting clinical trials.”

The IEEE SA DCT IC program plans to address those concerns. The group is recruiting members from academia, biology and pharmaceutical companies, the tech community, and regulators across the globe. Individual workstream groups are already looking at developing a variety of protocols, remotely monitoring participants, improving the logistics of shipping clinical trial kits to participants, and gathering and validating trial data. The program is also considering how to enable a more inclusive patient recruitment process with increased participation from minority groups, which are often underrepresented in clinical trials.

Learn More